Multicenter,Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as MonotherapyorFirst Adjunctive Therapy in SubjectsWith Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic

Administered By

Awarded By

Contributors

Start/End

  • March 13, 2018 - December 31, 2021